Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) PT at $8.25

LifeStance Health Group, Inc. (NASDAQ:LFST) has received an average rating of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $8.25.

LFST has been the topic of a number of research analyst reports. UBS Group cut their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, August 15th. Barclays cut their price objective on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a report on Friday, August 9th.

LifeStance Health Group Price Performance

NASDAQ:LFST opened at $6.71 on Tuesday. LifeStance Health Group has a 52 week low of $4.64 and a 52 week high of $9.20. The stock’s fifty day moving average is $6.83 and its two-hundred day moving average is $6.15. The company has a market capitalization of $2.57 billion, a P/E ratio of -16.37 and a beta of 1.24. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. The firm had revenue of $312.30 million for the quarter, compared to analyst estimates of $305.85 million. LifeStance Health Group had a negative net margin of 13.05% and a negative return on equity of 10.51%. LifeStance Health Group’s revenue was up 20.3% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.13) EPS. Equities analysts expect that LifeStance Health Group will post -0.24 EPS for the current year.

Insiders Place Their Bets

In other news, insider Ann Varanakis sold 5,269 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the sale, the insider now directly owns 263,007 shares in the company, valued at approximately $1,651,683.96. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

Large investors have recently made changes to their positions in the company. ProShare Advisors LLC grew its holdings in LifeStance Health Group by 8.5% during the 1st quarter. ProShare Advisors LLC now owns 19,069 shares of the company’s stock worth $118,000 after acquiring an additional 1,500 shares in the last quarter. Bessemer Group Inc. grew its stake in shares of LifeStance Health Group by 43.4% during the first quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock worth $56,000 after purchasing an additional 2,768 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of LifeStance Health Group by 27.0% during the second quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after purchasing an additional 3,063 shares in the last quarter. SG Americas Securities LLC increased its holdings in LifeStance Health Group by 8.7% in the first quarter. SG Americas Securities LLC now owns 44,925 shares of the company’s stock valued at $277,000 after buying an additional 3,600 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in LifeStance Health Group by 12.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 42,366 shares of the company’s stock valued at $262,000 after buying an additional 4,681 shares in the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.